Bernard Haendler

16PUBLICATIONS
29CO-AUTHORS
Biologically active moleculesMolecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 26, 2026
Targeting the Androgen Receptor and Associated Cofactors in Prostate Cancer: Novel Approaches and Future Perspectives.

|Jan 17, 2025
Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis.

Weronika Trun, Amaury Fernández-Montalván, Yong-Jiang Cao

|Jan 08, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer Models.

Urs B Hagemann, Christoph A Schatz, Mari I Suominen

|Apr 09, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.

Christoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen

|Jan 23, 2024
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review.

Paulina J Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler

|Jan 15, 2024
Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.

Tatsuo Sugawara, Ekaterina Nevedomskaya, Simon Heller

Pageof 3

Frequent Collaborators

2 joint publications

Stefanie Hammer

2 joint publications

Andreas Schlicker

2 joint publications

Sabine Zitzmann-Kolbe

2 joint publications

Jenny Karlsson